HAEMONETICS CORPORATION (HAE) Stock buybacks 2017–2026
HAEMONETICS CORPORATION (HAE) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$175.0MFY2026 · since FY2017: $0 → $175.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $175.0M | -22.2% |
| FY2025 | $225.0M | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $75.0M | — |
| FY2022 | $0 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $175.0M | +9.4% |
| FY2019 | $160.0M | +60.0% |
| FY2018 | $100.0M | — |
| FY2017 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice